Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses

BACKGROUND: Glioma is a common tumor originating from the glial cells of the brain. Immune checkpoint inhibitors can potentially be used to treat gliomas, although no drug is currently approved. METHODS: The expression levels of the immune checkpoint genes in glioma and normal tissues, and their cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Mengmeng, Li, Yong-an, Lu, Zhimin, Hou, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860561/
https://www.ncbi.nlm.nih.gov/pubmed/35198632
http://dx.doi.org/10.1155/2022/1734847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860561/
https://www.ncbi.nlm.nih.gov/pubmed/35198632
http://dx.doi.org/10.1155/2022/1734847

Ejemplares similares